Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T55012
(Former ID: TTDI01612)
|
|||||
Target Name |
Ion channel unspecific (IC)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 2 Target-related Diseases | + | ||||
1 | Bipolar disorder [ICD-11: 6A60] | |||||
2 | Supraventricular tachyarrhythmia [ICD-11: BC81] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 3 Clinical Trial Drugs | + | ||||
1 | ATI-2042 | Drug Info | Phase 2 | Atrial fibrillation | [2] | |
2 | AZD-2927 | Drug Info | Phase 2 | Atrial fibrillation | [3], [4] | |
3 | Lu-AA39959 | Drug Info | Phase 2 | Bipolar disorder | [5] | |
Discontinued Drug(s) | [+] 2 Discontinued Drugs | + | ||||
1 | Lu-AA38466 | Drug Info | Discontinued in Phase 1 | Neurological disorder | [6] | |
2 | AZD-0902 | Drug Info | Terminated | Rheumatoid arthritis | [7] | |
Mode of Action | [+] 2 Modes of Action | + | ||||
Antagonist | [+] 2 Antagonist drugs | + | ||||
1 | ATI-2042 | Drug Info | [8] | |||
2 | AZD-0902 | Drug Info | [10] | |||
Modulator | [+] 3 Modulator drugs | + | ||||
1 | AZD-2927 | Drug Info | [3] | |||
2 | Lu-AA39959 | Drug Info | [1] | |||
3 | Lu-AA38466 | Drug Info | [9] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Lundbeck: leading the way in the treatment of CNS disorders. | |||||
REF 2 | ClinicalTrials.gov (NCT00389792) Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers. U.S. National Institutes of Health. | |||||
REF 3 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7704). | |||||
REF 4 | ClinicalTrials.gov (NCT01396226) A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients. U.S. National Institutes of Health. | |||||
REF 5 | ClinicalTrials.gov (NCT00771134) Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression. U.S. National Institutes of Health. | |||||
REF 6 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029333) | |||||
REF 7 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019129) | |||||
REF 8 | A randomized trial of budiodarone in paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2012 Jun;34(1):1-9. | |||||
REF 9 | Lundbeck is developing new and promising pharmaceuticals for the treatment of depression, anxiety and psychotic disorders and for new disease areas such as stroke and alcohol dependence. Pipeline report of Lundbeck in 2008. | |||||
REF 10 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019129) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.